These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8840867)

  • 1. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist.
    Glover DK; Ruiz M; Yang JY; Koplan BA; Allen TR; Smith WH; Watson DD; Barrett RJ; Beller GA
    Circulation; 1996 Oct; 94(7):1726-32. PubMed ID: 8840867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosine.
    Glover DK; Ruiz M; Sansoy V; Barrett RJ; Beller GA
    J Nucl Med; 1995 Feb; 36(2):270-5. PubMed ID: 7830130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow.
    Glover DK; Ruiz M; Yang JY; Smith WH; Watson DD; Beller GA
    Circulation; 1997 Oct; 96(7):2332-8. PubMed ID: 9337208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging.
    Trochu JN; Zhao G; Post H; Xu X; Belardinelli L; Belloni FL; Hintze TH
    J Cardiovasc Pharmacol; 2003 Jan; 41(1):132-9. PubMed ID: 12500031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A(2A) receptor agonist.
    He ZX; Cwajg E; Hwang W; Hartley CJ; Funk E; Michael LH; Verani MS
    Circulation; 2000 Jul; 102(4):438-44. PubMed ID: 10908217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.
    Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L
    Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability.
    Sansoy V; Glover DK; Watson DD; Ruiz M; Smith WH; Simanis JP; Beller GA
    Circulation; 1995 Aug; 92(4):994-1004. PubMed ID: 7641384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.
    Gao Z; Li Z; Baker SP; Lasley RD; Meyer S; Elzein E; Palle V; Zablocki JA; Blackburn B; Belardinelli L
    J Pharmacol Exp Ther; 2001 Jul; 298(1):209-18. PubMed ID: 11408544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive detection of subcritical coronary arterial narrowings with a coronary vasodilator and myocardial perfusion imaging.
    Strauss HW; Pitt B
    Am J Cardiol; 1977 Mar; 39(3):403-6. PubMed ID: 842459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog.
    Akatsuka Y; Egashira K; Katsuda Y; Narishige T; Ueno H; Shimokawa H; Takeshita A
    Cardiovasc Res; 1994 Jun; 28(6):906-11. PubMed ID: 7923297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity.
    Glover DK; Ruiz M; Edwards NC; Cunningham M; Simanis JP; Smith WH; Watson DD; Beller GA
    Circulation; 1995 Feb; 91(3):813-20. PubMed ID: 7828310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracoronary dipyridamole infusion on regional myocardial blood flow and intrinsic thallium-201 washout in dogs with a critical coronary stenosis.
    Beller GA; Granato JE; Cannon JM; Belardinelli L; Watson DD
    Am Heart J; 1992 Jul; 124(1):56-64. PubMed ID: 1615828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
    Hein TW; Wang W; Zoghi B; Muthuchamy M; Kuo L
    J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis.
    Granato JE; Watson DD; Belardinelli L; Cannon JM; Beller GA
    J Am Coll Cardiol; 1990 Dec; 16(7):1760-70. PubMed ID: 2254563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic stress-induced regional myocardial blood flow heterogeneity and left ventricular wall thickening abnormality: comparison of intravenous adenosine with dipyridamole in a model of critical coronary stenosis.
    Ofili EO; Dressler FA; St Vrain JA; Goodgold H; Standeven J; Chandel B; Gentilcore R; McBride L; Castello R; Kern M; Labovitz AJ
    Am Heart J; 1997 Jan; 133(1):78-86. PubMed ID: 9006294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
    Khalil A; Carrier M; Latour JG; Pelletier LC
    Circulation; 1996 Nov; 94(9 Suppl):II308-11. PubMed ID: 8901766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
    Casati C; Forlani A; Lozza G; Monopoli A
    Pharmacol Res; 1997 Jan; 35(1):51-5. PubMed ID: 9149316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
    Conti A; Lozza G; Monopoli A
    Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.